TWI494138B - Method for preparing antibacterial non-woven fabric - Google Patents

Method for preparing antibacterial non-woven fabric Download PDF

Info

Publication number
TWI494138B
TWI494138B TW101121756A TW101121756A TWI494138B TW I494138 B TWI494138 B TW I494138B TW 101121756 A TW101121756 A TW 101121756A TW 101121756 A TW101121756 A TW 101121756A TW I494138 B TWI494138 B TW I494138B
Authority
TW
Taiwan
Prior art keywords
group
antibacterial
woven fabric
nonwoven fabric
wound
Prior art date
Application number
TW101121756A
Other languages
Chinese (zh)
Other versions
TW201400152A (en
Inventor
Shen Cherng
Original Assignee
Shen Cherng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shen Cherng filed Critical Shen Cherng
Priority to TW101121756A priority Critical patent/TWI494138B/en
Publication of TW201400152A publication Critical patent/TW201400152A/en
Application granted granted Critical
Publication of TWI494138B publication Critical patent/TWI494138B/en

Links

Description

抗菌不織布製備方法Antibacterial non-woven fabric preparation method

  本發明係有關於一種抗菌不織布製備方法,尤其是指一種具有抑制傷口紗布上細菌及微生物的生長和繁殖之抗菌不織布製備方法。The present invention relates to a method for preparing an antibacterial nonwoven fabric, and more particularly to a method for preparing an antibacterial nonwoven fabric having the growth and reproduction of bacteria and microorganisms on wound gauze.

  按,皮膚為人體最大的組織結構,不僅具有體溫調節以及調節體內水分平衡的功能,更是人體防禦外界病原入侵的第一道防線;而當皮膚大面積受傷時,可能會造成身體功能失衡,臟器嚴重失調,甚至因而死亡;一般來說,皮膚傷口經藥物處理後,仍會與衣物或是外界接觸,不小心即可能會因受到碰撞或沾染空氣中的灰塵或細菌,而導致傷口惡化的情形。According to the skin, the skin is the largest tissue structure of the human body. It not only has the function of regulating body temperature and regulating the water balance in the body, but also the first line of defense against the invasion of external pathogens. When the skin is injured in a large area, it may cause imbalance of body function. Organs are seriously dysfunctional and even die; in general, skin wounds are still in contact with clothing or the outside world after being treated with drugs. If they are accidentally caught, they may be damaged by dust or bacteria in the air. The situation.

  因此為了要避免傷口暴露於空氣中,人們通常會在處理過的傷口上覆蓋OK繃直接包紮或以紗布及膠帶將傷口包覆起來,用以保護傷口;然,一般的OK繃或紗布,僅具隔離傷口以避免與外界接觸之功效,當紗布不小心被水弄濕或包覆時間過長未更換時,紗布易滋生細菌而變成細菌的溫床,導致傷口持續受到細菌的感染而引起更嚴重的發炎反應。Therefore, in order to avoid exposure of the wound to the air, people usually cover the wound with a straight stretch or wrap the wound with gauze and tape to protect the wound; however, the general OK stretch or gauze, only With the effect of isolating the wound to avoid contact with the outside world, when the gauze is accidentally wetted by water or the coating is too long to be replaced, the gauze is easy to breed bacteria and become a hotbed of bacteria, causing the wound to continue to be infected by bacteria and causing more serious damage. Inflammatory response.

  今,發明人即是鑑於上述現有之傷口紗布在實際實施上仍具有多處之缺失,於是乃一本孜孜不倦之精神,並藉由其豐富之專業知識及多年之實務經驗所輔佐,而加以改善,並據此研創出本發明。Nowadays, the inventor is still in the light of the insatiable spirit of the above-mentioned existing wound gauze, and it is improved by the rich professional knowledge and years of practical experience. And based on this, the present invention was developed.

  本發明主要目的為提供一種具有抑制傷口紗布上細菌及微生物的生長和繁殖之抗菌不織布製備方法。SUMMARY OF THE INVENTION A primary object of the present invention is to provide a method for preparing an antibacterial nonwoven fabric having the growth and reproduction of bacteria and microorganisms on wound gauze.

  為了達到上述實施目的,本發明人乃研擬如下實施技術,首先將一第一賦型劑、一奈米銀多孔性複合材以及一第一多醣體混合,加熱並持續攪拌直到第一多醣體完全溶解,成為一基材;接著,以濾網版加壓塗佈方式將基材均勻網印於纖維性不織布上,並使水分完全除去,即可形成一乾燥且具有特定厚度之抗菌不織布。In order to achieve the above-mentioned purposes, the inventors have developed the following implementation techniques, first mixing a first excipient, a nano-silver porous composite, and a first polysaccharide, heating and stirring until the first The saccharide is completely dissolved to form a substrate; then, the substrate is uniformly screen printed on the fibrous non-woven fabric by screen coating, and the moisture is completely removed to form a dry and specific thickness antibacterial. Not woven.

  如上所述的抗菌不織布製備方法,其中第一賦型劑可選自澱粉、甘露醇、乳糖、山梨醇以及聚乙二醇所組成之族群;較佳地,第一賦型劑係選自山梨醇。The antibacterial nonwoven fabric preparation method as described above, wherein the first excipient is selected from the group consisting of starch, mannitol, lactose, sorbitol, and polyethylene glycol; preferably, the first excipient is selected from the group consisting of Yamanashi alcohol.

  如上所述的抗菌不織布製備方法,其中第一多醣體係具有羧基之官能基;較佳地,第一多醣體係為褐藻酸鈉。The antibacterial nonwoven fabric preparation method as described above, wherein the first polysaccharide system has a functional group of a carboxyl group; preferably, the first polysaccharide system is sodium alginate.

  如上所述的抗菌不織布製備方法,其中於製備基材時,可進一步加入一保濕劑,保濕劑係選自山梨醇、玻尿酸原液、植物性甘油、維他命B5、尿囊素、尿素以及其等之混合物所組成之族群;藉此,以保持創傷面濕度,進而減少傷口疼痛,加速創傷面上皮的癒合。The antibacterial non-woven fabric preparation method as described above, wherein a humectant is further added to the preparation of the substrate, and the humectant is selected from the group consisting of sorbitol, hyaluronic acid stock solution, vegetable glycerin, vitamin B5, allantoin, urea, and the like. The group of the mixture; thereby, to maintain the wound surface moisture, thereby reducing wound pain and accelerating the healing of the wound surface.

  如上所述的抗菌不織布製備方法,其中於製備基材時,可進一步加入一增稠劑,而增稠劑可選自褐藻酸、聚麩胺酸、聚乙烯醇、幾丁聚醣以及其等之混合物所組成之族群。The antibacterial non-woven fabric preparation method as described above, wherein in the preparation of the substrate, a thickener may be further added, and the thickener may be selected from the group consisting of alginic acid, polyglutamic acid, polyvinyl alcohol, chitosan, and the like. a group of mixtures.

  藉此,利用褐藻酸鈉與奈米銀多孔性複合材混合所形成的抗菌基材,其奈米銀多孔性複合材可隔離外界細菌,而褐藻酸鈉則用以促進傷口新生組織的再生,達到抗感染及促進傷口癒合速度,進而減少傷口感染的機會以及患者換藥的次數。Thereby, the antibacterial substrate formed by mixing the sodium alginate and the nano silver porous composite material, the nano silver porous composite material can isolate the external bacteria, and the sodium alginate is used to promote the regeneration of the wound new tissue. Achieve anti-infection and promote wound healing speed, thereby reducing the chance of wound infection and the number of patients changing dressings.

  此外,本發明將抗菌基材以濾網版加壓塗佈方式網印於纖維性不織布上,因不織布之紋理結構以及毛細孔均較細緻,其與傷口接觸時,觸感較為柔細,且若與傷口連結時,僅需加入少量的水即可令不織布與傷口處分開,解決傳統欲撕下OK繃或紗布時不僅疼痛難耐,且會再度將愈合或結痂之傷口撕開的問題。In addition, in the present invention, the antibacterial substrate is screen printed on the fibrous non-woven fabric by a screen printing method, and the texture structure and the capillary pores of the non-woven fabric are finer, and the touch is softer when it comes into contact with the wound. When connecting with the wound, it is only necessary to add a small amount of water to separate the non-woven fabric from the wound, and solve the problem that the traditional to tear off the OK stretch or gauze is not only painful, but also tears the wound which is healed or crusted again.

  再者,本發明利用濾網版加壓塗佈網印的方式,將抗菌基材均勻網印於纖維性不織布上,其網印方式不同於傳統之浸漬法(dipping)、噴霧法或板刮方式等,使得本發明可準確地控制不織布之厚度。Furthermore, the present invention utilizes a screen printing and screen printing method to uniformly screen the antibacterial substrate on the fibrous non-woven fabric, and the screen printing method is different from the traditional dipping method, the spray method or the plate scraping method. The method and the like enable the present invention to accurately control the thickness of the nonwoven fabric.

  本發明之目的及其結構功能上的優點,將依據以下圖面所示之結構,配合具體實施例予以說明,俾使審查委員能對本發明有更深入且具體之瞭解。
  首先,請參照第一圖所示,為本發明抗菌不織布製備方法其較佳實施例的步驟流程圖,其包括下述步驟:
The object of the present invention and its structural and functional advantages will be explained in conjunction with the specific embodiments according to the structure shown in the following drawings, so that the reviewing committee can have a more in-depth and specific understanding of the present invention.
First, please refer to the first figure, which is a flow chart of a preferred embodiment of the method for preparing an antibacterial nonwoven fabric of the present invention, which comprises the following steps:

  步驟一(S1):將一第一賦型劑、一奈米銀多孔性複合材以及一第一多醣體混合,加熱並持續攪拌直到第一多醣體完全溶解,成為一基材;其中,第一多醣體係具有羧基(carboxyl)之官能基,較佳地,第一多醣體係為褐藻酸鈉(alginate),其中褐藻酸(alginic acid)係由褐海藻中得到之不溶性膠體酸,為一群含有不同比例之D-甘露糖醛酸(D-mannuronic acid)及L-古羅糖醛酸(L-guluronic acid)聚合物,這些糖醛酸以α-1﹐4及β-1﹐4鍵結成線形聚合物,分子量約為240﹐000,鈉鹽可溶於水,鈣鹽不溶於水;值得注意的,上述奈米銀多孔性複合材之製備方法係適用於本案申請人於101年4月16日申請之中華民國發明專利(申請號第101113509號)所揭露者,該案『具奈米銀之多孔性抗菌複合材料的製備方法』之內容係作為本案之參考資料;Step 1 (S1): mixing a first excipient, a nano-silver porous composite and a first polysaccharide, heating and stirring until the first polysaccharide is completely dissolved to form a substrate; The first polysaccharide system has a carboxyl group functional group. Preferably, the first polysaccharide system is alginate, wherein the alginate acid is an insoluble colloidal acid obtained from brown seaweed. For a group of D-mannuronic acid and L-guluronic acid polymers containing different ratios, these uronic acids are α-1,4 and β-1, The 4-bond is a linear polymer with a molecular weight of about 240,000. The sodium salt is soluble in water and the calcium salt is insoluble in water. It is worth noting that the preparation method of the above nano-silver porous composite is suitable for the applicant of the present invention. Application for the Republic of China invention patent on April 16 (application number 10111) No. 3509), the content of the "Preparation method of nano-silver porous antibacterial composite material" is the reference material of this case;

  步驟二(S2):以濾網版加壓塗佈方式將基材均勻網印於纖維性不織布上,並使水分完全除去,即可形成一乾燥且具有特定厚度之抗菌不織布;其中,濾網版加壓塗佈網印方式係將基材塗佈於特殊大小之濾網,再於適當壓力下網印於纖維性不織布上;Step 2 (S2): the substrate is uniformly screen printed on the fibrous non-woven fabric by a screen printing method, and the moisture is completely removed, thereby forming a dry and specific thickness antibacterial non-woven fabric; wherein, the filter mesh Press-coating screen printing method is to apply the substrate to a special size filter screen, and then screen printing on the fibrous non-woven fabric under appropriate pressure;

  再者,第一賦型劑可選自澱粉、甘露醇(mannitol)、乳糖(lactose)、山梨醇(sorbitol)以及聚乙二醇(polyethylene glycol,PEG)所組成之族群;較佳地,第一賦型劑係選自山梨醇。Furthermore, the first excipient may be selected from the group consisting of starch, mannitol, lactose, sorbitol, and polyethylene glycol (PEG); preferably, An excipient is selected from the group consisting of sorbitol.

  此外,於上述步驟一(S1)進行時,可進一步加入一保濕劑,保濕劑係選自山梨醇、玻尿酸原液、植物性甘油(vegetable glycerin)、維他命B5、尿囊素(allantoin)、尿素(urea)以及其等之混合物所組成之族群。In addition, in the above step (S1), a moisturizing agent may be further added, and the moisturizing agent is selected from the group consisting of sorbitol, hyaluronic acid stock solution, vegetable glycerin, vitamin B5, allantoin, urea ( Urea) and the group of its mixture.

  再者,亦可於上述步驟一(S1)進行時,進一步加入一增稠劑,而增稠劑可選自褐藻酸(alginic acid)、聚麩胺酸(poly(γ-glutamic acid))、聚乙烯醇(polyvinyl alcohol)、幾丁聚醣以及其等之混合物所組成之族群。Further, when the first step (S1) is performed, a thickener may be further added, and the thickener may be selected from the group consisting of alginate, poly(gamma-glutamic acid), A group consisting of polyvinyl alcohol, chitosan, and mixtures thereof.

  此外,藉由下述實際實施例,可進一步證明本發明之製程可實際應用之範圍,但不意欲以任何形式限制本發明之範圍:In addition, the scope of the invention may be further demonstrated by the following practical embodiments, but is not intended to limit the scope of the invention in any way:

  首先,取20g的硝酸銀晶體溶於80g的去離子水,配置成重量百分比20%的硝酸銀溶液;再取37﹒8mL的硝酸銀溶液溶於500mL的去離子水,製得溶液A;接著,將10g的明膠溶於300mL的去離子水,並將溫度保持在攝氏40度,持續攪拌使明膠溶解均勻;然後,將溶液A倒入並持續攪拌以製得溶液B;取0﹒2g硼氫化鈉溶於100mL去離子水,並加入溶液B,以使溶液B中之銀離子可還原成為銀粒子,製得溶液C,而其銀離子可還原成為銀粒子之化學反應式如下:First, 20 g of silver nitrate crystals were dissolved in 80 g of deionized water and placed in a 20% by weight silver nitrate solution; then 37.8 mL of silver nitrate solution was dissolved in 500 mL of deionized water to prepare a solution A; then, 10 g was obtained. The gelatin is dissolved in 300 mL of deionized water, and the temperature is maintained at 40 ° C. Stirring is continued to dissolve the gelatin uniformly; then, the solution A is poured and continuously stirred to prepare a solution B; 0.2 g of sodium borohydride is dissolved. In 100 mL of deionized water, and adding Solution B, the silver ions in Solution B can be reduced to silver particles to prepare Solution C, and the chemical reaction formula of the silver ions which can be reduced to silver particles is as follows:

  接著,將以氫氧化鈉製成之鹼液滴入溶液C,調整溶液C之pH至6,並將溫度保持在攝氏40度,以製得溶液D;然後,取40g的矽酸鈉溶於500mL去離子水,攪拌使其溶解均勻,製得鹼性溶液E;將10mL的鹽酸加入300ml去離子水配製成為一酸液,製得溶液F;將溶液F快速倒入溶液E中,快速攪拌使得溶液pH值迅速下降至約1﹒5,製得強酸性溶液G;接著,將溶液G緩慢滴入以氫氧化鈉配置而成之鹼液,使其pH值調整為6,製得弱酸性溶液H;最後,再將溶液D快速倒入溶液H中,混合即得到銀-氧化矽錯合物之奈米銀多孔性複合材,亦即銀粒子可被包覆於多孔性之氧化矽矽膠結構中。 Next, the alkali made of sodium hydroxide is dropped into the solution C, the pH of the solution C is adjusted to 6, and the temperature is maintained at 40 degrees Celsius to prepare the solution D; then, 40 g of sodium citrate is dissolved. 500mL deionized water, stirred to dissolve evenly, to obtain an alkaline solution E; 10mL of hydrochloric acid was added to 300ml of deionized water to prepare an acid solution to prepare a solution F; the solution F was quickly poured into the solution E, and rapidly stirred The pH of the solution is rapidly lowered to about 1.5 to prepare a strongly acidic solution G. Then, the solution G is slowly dropped into the alkali solution prepared by using sodium hydroxide to adjust the pH to 6 to obtain a weak acidity. Solution H; finally, the solution D is quickly poured into the solution H, and mixed to obtain a nano-silver porous composite of silver-yttria complex, that is, the silver particles can be coated on the porous cerium oxide rubber. In the structure.

  接著,取8g的去離子水與2g的山梨醇溶液均勻混合,並加入上述0﹒01g的奈米銀多孔性複合材,利用超音波振盪使其均勻分散,再添加褐藻酸鈉1g,加熱至100℃並持續攪拌,直到完全溶解均勻,配置出含銀量3000ppm的基材;接續,以特殊大小及厚度之濾網將上述基材於適當之壓力(例如1﹒5atm)下網印於纖維性不織布上,加熱至80℃並維持1小時,使水分完全除去,即形成一乾燥且具有特定厚度之抗菌不織布;使用時,可任意剪裁大小直接於傷口處使用,解決傳統傷口紗布易滋生細菌而變成細菌的溫床,導致傷口持續受到細菌感染之問題;值得注意的,濾網網格之大小係決定基材薄膜之厚度,通常網格之孔隙度可為500μm~100μm之間。Next, 8 g of deionized water and 2 g of sorbitol solution were uniformly mixed, and 0.01 g of the nano silver porous composite material was added thereto, and uniformly dispersed by ultrasonic vibration, and then 1 g of sodium alginate was added thereto, and heated to 100 ° C and continuous stirring until completely dissolved, configure a substrate containing 3000 ppm of silver; followed by a special size and thickness of the screen to screen the substrate at a suitable pressure (for example, 1.5 atm) on the fiber On the non-woven fabric, heat to 80 ° C and maintain for 1 hour, so that the moisture is completely removed, that is, a dry and specific thickness of the antibacterial non-woven fabric; when used, can be used to cut the size directly to the wound, to solve the traditional wound gauze susceptible bacteria It becomes a hotbed of bacteria, which causes the wound to continue to be infected by bacteria. It is worth noting that the size of the mesh grid determines the thickness of the substrate film. Generally, the porosity of the mesh may be between 500 μm and 100 μm.

  由上述之抗菌不織布製備方法與實施說明可知,本發明具有以下優點:It can be seen from the above preparation method and implementation description of the antibacterial non-woven fabric that the present invention has the following advantages:

  1. 本發明藉由褐藻酸鈉與奈米銀多孔性複合材混合所形成的抗菌基材,其奈米銀多孔性複合材隔離外界細菌,而褐藻酸鈉則用以促進傷口新生組織的再生,達到抗感染及促進傷口癒合速度,進而減少傷口感染的機會以及患者換藥的次數。The invention comprises an antibacterial substrate formed by mixing a sodium alginate and a nano silver porous composite material, wherein the nano silver porous composite material isolates external bacteria, and the sodium alginate is used to promote regeneration of wound new tissue. Anti-infection and promote the speed of wound healing, thereby reducing the chance of wound infection and the number of patients changing dressings.
  2. 本發明將抗菌基材以濾網版加壓塗佈方式網印於纖維性不織布上,因不織布之紋理結構以及毛細孔均較細緻,其與傷口接觸時,觸感較為柔細,且若與傷口連結時,僅需加入少量的水即可令不織布與傷口處分開,可解決傳統欲撕下OK繃或紗布時不僅疼痛難耐,且會再度將愈合或結痂之傷口撕開的問題。In the invention, the antibacterial substrate is screen printed on the fibrous non-woven fabric by the screen printing method, and the texture structure and the capillary pores of the non-woven fabric are finer, and the touch is softer when in contact with the wound, and if the wound is wounded When connecting, it is only necessary to add a small amount of water to separate the non-woven fabric from the wound. It can solve the problem that the traditional to tear off the OK stretch or gauze is not only painful, but also tears the wound which is healed or crusted again.
  3. 本發明利用濾網版加壓塗佈網印的方式,將抗菌基材均勻網印於纖維性不織布上,其網印方式不同於傳統之浸漬法(dipping)、噴霧法或板刮方式等,使得本發明可準確地控制不織布之厚度。The invention utilizes the method of screen coating by pressure screen printing to uniformly screen the antibacterial substrate on the fibrous non-woven fabric, and the screen printing method is different from the traditional dipping method, the spraying method or the plate scraping method. This makes it possible to accurately control the thickness of the nonwoven fabric.
  4. 本發明之抗菌不織布製備方法可藉由保濕劑的添加,以保持創傷面濕度,進而減少傷口疼痛,加速創傷面上皮的癒合。The antibacterial non-woven fabric preparation method of the present invention can maintain the wound surface moisture by the addition of a moisturizing agent, thereby reducing wound pain and accelerating the healing of the wound surface.

  綜上所述,本發明之抗菌不織布製備方法,的確能藉由上述所揭露之實施例,達到所預期之使用功效,且本發明亦未曾公開於申請前,誠已完全符合專利法之規定與要求。爰依法提出發明專利之申請,懇請惠予審查,並賜准專利,則實感德便。In summary, the preparation method of the antibacterial non-woven fabric of the present invention can achieve the intended use efficiency by the above-mentioned disclosed embodiments, and the present invention has not been disclosed before the application, and has completely complied with the provisions of the patent law. Claim.爰Issuing an application for a patent for invention in accordance with the law, and asking for a review, and granting a patent, is truly sensible.

  惟,上述所揭之圖示及說明,僅為本發明之較佳實施例,非為限定本發明之保護範圍;大凡熟悉該項技藝之人士,其所依本發明之特徵範疇,所作之其它等效變化或修飾,皆應視為不脫離本發明之設計範疇。The illustrations and descriptions of the present invention are merely preferred embodiments of the present invention, and are not intended to limit the scope of the present invention; those skilled in the art, which are characterized by the scope of the present invention, Equivalent variations or modifications are considered to be within the scope of the design of the invention.

(S1)...步驟一(S1). . . step one

(S2)...步驟二(S2). . . Step two

第一圖:本發明之製備方法步驟流程圖First Figure: Flow chart of the preparation method of the present invention

(S1)...步驟一(S1). . . step one

(S2)...步驟二(S2). . . Step two

Claims (7)

一種抗菌不織布製備方法,係包括有下述步驟:步驟一:將一第一賦型劑、一奈米銀多孔性複合材以及一第一多醣體混合,加熱並持續攪拌直到該第一多醣體完全溶解,成為一基材,其中,奈米銀多孔性複合材是一種具有銀粒子可被包覆於多孔性之氧化矽矽膠結構中之複合材料;以及步驟二:以濾網版加壓塗佈方式將該基材均勻網印於纖維性不織布上,並使水分完全除去,形成一乾燥且具有特定厚度之抗菌不織布。 An antibacterial non-woven fabric preparation method comprises the following steps: Step 1: mixing a first excipient, a nano-silver porous composite and a first polysaccharide, heating and stirring until the first plurality The saccharide is completely dissolved and becomes a substrate, wherein the nano-silver porous composite is a composite material having silver particles which can be coated in the porous cerium oxide structure; and step 2: adding the sieve plate The substrate is uniformly screen printed on the fibrous nonwoven fabric by press coating, and the moisture is completely removed to form an antibacterial nonwoven fabric which is dry and has a specific thickness. 如申請專利範圍第1項所述之抗菌不織布製備方法,其中該第一賦型劑選自澱粉、甘露醇(mannitol)、乳糖(lactose)、山梨醇(sorbitol)以及聚乙二醇(polyethylene glycol,PEG)所組成之族群。 The antibacterial non-woven fabric preparation method according to claim 1, wherein the first excipient is selected from the group consisting of starch, mannitol, lactose, sorbitol, and polyethylene glycol. , PEG) group of people. 如申請專利範圍第2項所述之抗菌不織布製備方法,其中該第一賦型劑係選自山梨醇。 The antibacterial nonwoven fabric preparation method according to claim 2, wherein the first excipient is selected from the group consisting of sorbitol. 如申請專利範圍第1項所述之抗菌不織布製備方法,其中該第一多醣體係具有羧基(carboxyl)之官能基。 The antibacterial nonwoven fabric preparation method according to claim 1, wherein the first polysaccharide system has a carboxyl group functional group. 如申請專利範圍第4項所述之抗菌不織布製備方法,其中該第一多醣體係為褐藻酸鈉(alginate)。 The antibacterial nonwoven fabric preparation method according to claim 4, wherein the first polysaccharide system is alginate. 如申請專利範圍第1項所述之抗菌不織布製備方法,其中於該步驟一可進一步加入一保濕劑,該保濕劑係選自山梨醇、玻尿酸原液、植物性甘油(vegetable glycerin)、維他命B5、尿囊素(allantoi n)、尿素(urea)以及其等之混合物所組成之族群。 The antibacterial non-woven fabric preparation method according to claim 1, wherein in the step 1, a moisturizing agent is further added, which is selected from the group consisting of sorbitol, hyaluronic acid stock solution, vegetable glycerin, vitamin B5, Allantoin (allantoi a group of n), urea (urea), and mixtures thereof. 如申請專利範圍第1項所述之抗菌不織布製備方法,其中於該步驟一可進一步加入一增稠劑,該增稠劑係選自褐藻酸(alginic acid)、聚麩胺酸(poly(γ-glutamic acid))、聚乙烯醇(polyvinyl alcohol)、幾丁聚醣以及其等之混合物所組成之族群。 The method for preparing an antibacterial non-woven fabric according to claim 1, wherein a thickener is further added to the step 1, the thickener is selected from the group consisting of alginic acid and polyglutamic acid (poly(γ). - glutamic acid)), a group of polyvinyl alcohol, chitosan, and the like.
TW101121756A 2012-06-18 2012-06-18 Method for preparing antibacterial non-woven fabric TWI494138B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW101121756A TWI494138B (en) 2012-06-18 2012-06-18 Method for preparing antibacterial non-woven fabric

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW101121756A TWI494138B (en) 2012-06-18 2012-06-18 Method for preparing antibacterial non-woven fabric

Publications (2)

Publication Number Publication Date
TW201400152A TW201400152A (en) 2014-01-01
TWI494138B true TWI494138B (en) 2015-08-01

Family

ID=50344823

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101121756A TWI494138B (en) 2012-06-18 2012-06-18 Method for preparing antibacterial non-woven fabric

Country Status (1)

Country Link
TW (1) TWI494138B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI289443B (en) * 2005-11-04 2007-11-11 Chung Shan Inst Of Science Nano-silver medical dressing
TWI364272B (en) * 2003-06-16 2012-05-21 Univ Loma Linda Med Dry hemostatic material and preparation process thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI364272B (en) * 2003-06-16 2012-05-21 Univ Loma Linda Med Dry hemostatic material and preparation process thereof
TWI289443B (en) * 2005-11-04 2007-11-11 Chung Shan Inst Of Science Nano-silver medical dressing

Also Published As

Publication number Publication date
TW201400152A (en) 2014-01-01

Similar Documents

Publication Publication Date Title
CN104491914B (en) A kind of porous pluralgel-nanofiber oxygen flow dressing and preparation method thereof
CN102850598B (en) Alginate-gelatin-carboxymethylcellulose sodium blend membrane, and preparation and application thereof
CN111511411A (en) PH-adjusted wound dressing
CN103550817B (en) A kind of Bacterial cellulose/shitosan composite sponge dressing and preparation method thereof
CN102908653A (en) Preparation method of antiseptic dressing for deep infection wound
CN109731121A (en) A kind of preparation method of the cellulose containing mesoporous silicon oxide and chitosan combine dressing
CN103768650A (en) Wound regenerating and repairing bandage and manufacture method thereof
CN107496972B (en) Anti-adhesion wet dressing for promoting healing of burn wound and preparation method thereof
CN104623718A (en) Chitosan petrolatum gauze and preparation method thereof
CN104906623A (en) Cellulose-based dressing and preparation method and application thereof
CN109331215A (en) A kind of medical antibacterial sponge and preparation method thereof
TW201503917A (en) Medical material employing carboxymethyl cellulose
CN102921035A (en) Antiseptic dressing for deep infected wounds
KR101366417B1 (en) Covering material for antimicrobial moist wound and Method of manufacturing the same
CN104069535B (en) A kind of Preparation method and use of biological activity composite membrane bleeding-stopping dressing
CN101721733B (en) Medical chitosan antiseptic dressing and preparation method thereof
CN105536030A (en) Dressing chip with hemostasis and restoration promoting functions and preparation method thereof
Fu et al. Liquid handling properties of carboxymethyl modified chitosan nonwovens for medical dressings
WO2017028528A1 (en) Preparation method for polyurethane composite material and composite material obtained thereby
TWI494138B (en) Method for preparing antibacterial non-woven fabric
CN109200325B (en) Preparation method of self-adhesive wound dressing
CN108815554B (en) Preparation method of slow-release antibacterial medical dressing
CN106215221A (en) Oligochitosan gelatin akermanite nanofiber biological dressing and preparation method thereof
CN106729940B (en) Slow-release long-acting antibacterial silver-loaded dressing and preparation method thereof
TWI458470B (en) Method for preparing artificial skin dressing with antibacterial and hemostatic functions

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees